SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-24-007529 to PepGen Inc. (PEPG) (CIK 0001835597) (PEPG)

PepGen Inc. (PEPG) (CIK 0001835597)
Date: July 2, 2024 · CIK: 0001835597 · Accession: 0000000000-24-007529

AI Filing Summary & Sentiment

File numbers found in text: 333-280570

Date
July 2, 2024
Author
Not clearly detected
Form
UPLOAD
Company
PepGen Inc. (PEPG) (CIK 0001835597)

Letter

July 2, 2024 James McArthur, Ph.D. President and Chief Executive Officer PepGen Inc. 321 Harrison Avenue, 8th Floor Boston, Massachusetts 02118 Re:PepGen Inc. Registration Statement on Form S-3 Filed June 28, 2024 File No. 333-280570 Dear James McArthur Ph.D.: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at 202-551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Alicia Tschirhart, Esq.

Show Raw Text
July 2, 2024
James McArthur, Ph.D.
President and Chief Executive Officer
PepGen Inc.
321 Harrison Avenue, 8th Floor
Boston, Massachusetts 02118
Re:PepGen Inc.
Registration Statement on Form S-3
Filed June 28, 2024
File No. 333-280570
Dear James McArthur Ph.D.:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Chris Edwards at 202-551-6761 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Alicia Tschirhart, Esq.